TissGeneSummary for CCNA1 |
Gene summary |
Basic gene information | Gene symbol | CCNA1 |
Gene name | cyclin A1 | |
Synonyms | CT146 | |
Cytomap | UCSC genome browser: 13q12.3-q13 | |
Type of gene | protein-coding | |
RefGenes | NM_001111045.1, NM_001111046.1,NM_001111047.1,NM_003914.3, | |
Description | cyclin-A1 | |
Modification date | 20141207 | |
dbXrefs | MIM : 604036 | |
HGNC : HGNC | ||
Ensembl : ENSG00000133101 | ||
HPRD : 04946 | ||
Vega : OTTHUMG00000016733 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_CCNA1 | |
BioGPS: 8900 | ||
Pathway | NCI Pathway Interaction Database: CCNA1 | |
KEGG: CCNA1 | ||
REACTOME: CCNA1 | ||
Pathway Commons: CCNA1 | ||
Context | iHOP: CCNA1 | |
ligand binding site mutation search in PubMed: CCNA1 | ||
UCL Cancer Institute: CCNA1 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | TiGER,GTEx | |
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Bone marrowTestis | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | LAMLTGCT | |
Reference showing the relevant tissue of CCNA1 | ||
Description by TissGene annotations |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for CCNA1 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
HNSC | 2.985542445 | 0.697212213 | 2.288330233 | 1.83E-05 | 9.78E-05 |
THCA | 0.766071968 | -1.273846676 | 2.039918644 | 1.10E-09 | 6.31E-09 |
KIRC | -2.329671605 | -1.174520216 | -1.155151389 | 1.72E-07 | 4.71E-07 |
STAD | -2.772939314 | -1.282270564 | -1.49066875 | 5.43E-07 | 1.00E-05 |
LUAD | -0.422723473 | 1.057036872 | -1.479760345 | 0.000213 | 0.000509338 |
COAD | -2.946023208 | -1.760669362 | -1.185353846 | 0.00011 | 0.000395098 |
Top |
TissGene-miRNA for CCNA1 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for CCNA1 |
TissGeneSNV for CCNA1 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.V315I | COAD | 2 |
p.D315N | SKCM | 2 |
p.S13F | COAD | 1 |
p.D139N | SKCM | 1 |
p.H426Y | SKCM | 1 |
p.V358I | HNSC | 1 |
p.E26K | STAD | 1 |
p.D377H | LUAD | 1 |
p.S415* | UCEC | 1 |
p.L462F | SKCM | 1 |
p.M138I | SKCM | 1 |
p.M326V | SKCM | 1 |
p.Y22N | COAD | 1 |
p.S110P | LIHC | 1 |
p.G16W | THYM | 1 |
p.Q437K | SKCM | 1 |
p.Q350* | CESC | 1 |
p.R353Q | ESCA | 1 |
p.G289E | SKCM | 1 |
p.G27E | SKCM | 1 |
p.R360K | STAD | 1 |
p.T240M | UCEC | 1 |
p.Q36H | COAD | 1 |
p.L228M | COAD | 1 |
p.A112D | HNSC | 1 |
p.E2D | LUAD | 1 |
p.P377A | HNSC | 1 |
p.R278Q | COAD | 1 |
p.R354Q | ESCA | 1 |
p.A65G | LIHC | 1 |
p.E43G | HNSC | 1 |
p.K449R | STAD | 1 |
p.P79L | SKCM | 1 |
p.H383Y | SKCM | 1 |
p.L200I | ESCA | 1 |
p.I303M | STAD | 1 |
p.P115A | HNSC | 1 |
p.W360R | LGG | 1 |
p.R50M | COAD | 1 |
p.T315N | LUAD | 1 |
p.E406A | STAD | 1 |
p.D249V | STAD | 1 |
p.E300K | SKCM | 1 |
p.L122H | ESCA | 1 |
p.C452Y | OV | 1 |
p.E42G | HNSC | 1 |
p.G41W | COAD | 1 |
p.D376H | LUAD | 1 |
p.P79S | SKCM | 1 |
p.G27R | SKCM | 1 |
p.S108T | GBM | 1 |
p.R94W | CESC | 1 |
p.E213A | HNSC | 1 |
p.R359S | LUAD | 1 |
p.M455I | SKCM | 1 |
p.L305F | SKCM | 1 |
p.R244H | UCEC | 1 |
p.D272N | SKCM | 1 |
p.T264A | UCEC | 1 |
p.K233Q | SKCM | 1 |
p.R146K | SKCM | 1 |
p.T70P | STAD | 1 |
p.G255V | LUAD | 1 |
p.V357M | PAAD | 1 |
p.P73T | OV | 1 |
p.V186I | BLCA | 1 |
p.D316N | SKCM | 1 |
p.Q132K | SARC | 1 |
p.L121H | ESCA | 1 |
p.I104S | UCS | 1 |
p.L411F | SKCM | 1 |
p.G254V | LUAD | 1 |
p.T320A | STAD | 1 |
p.L190I | PAAD | 1 |
p.L454F | SKCM | 1 |
p.S13C | HNSC | 1 |
p.P140S | SKCM | 1 |
p.V187I | BLCA | 1 |
p.D273N | SKCM | 1 |
p.V254G | LUAD | 1 |
p.L386V | LUAD | 1 |
p.P378A | HNSC | 1 |
p.R61X | READ | 1 |
p.P304S | SKCM | 1 |
p.P183S | SKCM | 1 |
p.R360S | LUSC | 1 |
p.L191I | PAAD | 1 |
p.T69P | STAD | 1 |
p.T314N | LUAD | 1 |
p.L385V | LUAD | 1 |
p.F336Y | BLCA | 1 |
p.K259E | LIHC | 1 |
p.K234T | STAD | 1 |
p.Y10C | READ | 1 |
p.V359I | HNSC | 1 |
p.T407N | BRCA | 1 |
p.T101R | SKCM | 1 |
p.E309K | SKCM | 1 |
p.S48N | PAAD | 1 |
p.E26K | PRAD | 1 |
p.M95I | SKCM | 1 |
p.S107F | BLCA | 1 |
p.P122S | SKCM | 1 |
p.I103S | UCS | 1 |
p.E170X | COAD | 1 |
p.R261* | UCEC | 1 |
p.P122L | SKCM | 1 |
p.M412I | SKCM | 1 |
p.P114A | HNSC | 1 |
p.V356M | PAAD | 1 |
p.Q355H | UCEC | 1 |
p.W403R | LGG | 1 |
p.L348F | SKCM | 1 |
Top |
TissGeneCNV for CCNA1 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for CCNA1 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Top |
TissGeneNet for CCNA1 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for CCNA1 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for CCNA1 |
TissGeneDrug for CCNA1 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for CCNA1 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0023467 | Leukemia, Myelocytic, Acute | 11 | BeFree |
umls:C0007847 | Malignant tumor of cervix | 8 | BeFree |
umls:C0302592 | Cervix carcinoma | 8 | BeFree |
umls:C0023418 | leukemia | 7 | BeFree,LHGDN |
umls:C1168401 | Squamous cell carcinoma of the head and neck | 5 | BeFree,CTD_human |
umls:C0007137 | Squamous cell carcinoma | 3 | BeFree |
umls:C0027627 | Neoplasm Metastasis | 3 | BeFree |
umls:C0376358 | Malignant neoplasm of prostate | 3 | BeFree |
umls:C0596263 | Carcinogenesis | 3 | BeFree |
umls:C0600139 | Prostate carcinoma | 3 | BeFree |
umls:C0678222 | Breast Carcinoma | 3 | BeFree |
umls:C1334177 | Infiltrating Cervical Carcinoma | 3 | BeFree |
umls:C0004509 | Azoospermia | 2 | BeFree |
umls:C0006142 | Malignant neoplasm of breast | 2 | BeFree |
umls:C0009402 | Colorectal Carcinoma | 2 | BeFree |
umls:C0023449 | Acute lymphocytic leukemia | 2 | BeFree |
umls:C0033578 | Prostatic Neoplasms | 2 | BeFree,LHGDN |
umls:C0153594 | Malignant neoplasm of testis | 2 | BeFree |
umls:C0333875 | High-Grade Squamous Intraepithelial Lesions | 2 | BeFree |
umls:C0598766 | Leukemogenesis | 2 | BeFree |
umls:C0684249 | Carcinoma of lung | 2 | BeFree |
umls:C0751688 | Malignant Squamous Cell Neoplasm | 2 | BeFree |
umls:C1302773 | Low Grade Squamous Intraepithelial Neoplasia | 2 | BeFree |
umls:C1527249 | Colorectal Cancer | 2 | BeFree |
umls:C1961102 | Precursor Cell Lymphoblastic Leukemia Lymphoma | 2 | BeFree |
umls:C0005684 | Malignant neoplasm of urinary bladder | 1 | BeFree |
umls:C0005695 | Bladder Neoplasm | 1 | BeFree |
umls:C0007134 | Renal Cell Carcinoma | 1 | BeFree |
umls:C0007868 | Cervical dysplasia | 1 | BeFree |
umls:C0018939 | Hematological Disease | 1 | BeFree |
umls:C0019693 | HIV Infections | 1 | BeFree |
umls:C0021364 | Male infertility | 1 | BeFree,GAD |
umls:C0023464 | Acute biphenotypic leukemia | 1 | BeFree |
umls:C0023473 | Myeloid Leukemia, Chronic | 1 | BeFree |
umls:C0023890 | Liver Cirrhosis | 1 | BeFree |
umls:C0026764 | Multiple Myeloma | 1 | BeFree |
umls:C0035369 | Retroviridae Infections | 1 | BeFree |
umls:C0206708 | Cervical Intraepithelial Neoplasia | 1 | BeFree |
umls:C0238461 | Anaplastic thyroid carcinoma | 1 | BeFree |
umls:C0242379 | Malignant neoplasm of lung | 1 | BeFree |
umls:C0278996 | Cancer of Head and Neck | 1 | BeFree |
umls:C0349459 | Cervical intraepithelial neoplasia grade 2 | 1 | BeFree |
umls:C0376545 | Hematologic Neoplasms | 1 | BeFree |
umls:C0686619 | Secondary malignant neoplasm of lymph node | 1 | BeFree |
umls:C0699885 | Carcinoma of bladder | 1 | BeFree |
umls:C0855197 | Testicular malignant germ cell tumor | 1 | BeFree |
umls:C0950124 | Papillomavirus Infections | 1 | CTD_human |
umls:C1140680 | Malignant neoplasm of ovary | 1 | GAD |
umls:C1332922 | Cervical Squamous Intraepithelial Neoplasia | 1 | BeFree |
umls:C1334011 | High Grade Cervical Intraepithelial Neoplasia | 1 | BeFree |
umls:C1384583 | Congenital absence of germinal epithelium of testes | 1 | BeFree |
umls:C1458155 | Mammary Neoplasms | 1 | BeFree |
umls:C1561955 | Fibrinogen Adverse Event | 1 | GAD |
umls:C1623038 | Cirrhosis | 1 | BeFree |
umls:C2239176 | Liver carcinoma | 1 | CTD_human |
umls:C2931822 | Nasopharyngeal carcinoma | 1 | BeFree |